Antimicrobial Group | Amoxicillin, ciprofloxacin, amoxicillin/clavulanic acid, nitrofurantoin or trimethoprim | Nitrofurantoin or trimethoprim |
---|---|---|
Any | 1,093,227 (100.0%) | 752,225 (68.8%) |
Gender | ||
 Male  Female | 310,974 (28.4%) 782,253 (71.6%) | 137,198 (18.2%) 615,027 (81.8%) |
Age group | ||
 16-34  35-49  50-64   > 65 | 268,896 (24.6%) 242,173 (22.2%) 247,287 (22.6%) 334,871 (30.6%) | 184,476 (24.5%) 152,857 (20.3%) 160,108 (21.3%) 254,784 (33.9%) |
SIMD quintile (Q1 = Most Deprived, Q5 = Least Deprived) | ||
 Q1  Q2  Q3  Q4  Q5 | 247,671 (22.8%) 232,451 (21.4%) 215,015 (19.8%) 198,832 (18.3%) 190,210 (17.5%) | 169,301 (22.7%) 159,286 (21.4%) 147,401 (19.8%) 138,783 (18.6%) 131,272 (17.6%) |
Long-term users of any antimicrobials | ||
 Yes | 85,036 (7.8%) | 32,968 (4.4%) |
 No | 1,008,191 (92.2%) | 719,257 (95.6%) |
Treatment failures | ||
 | 195,184 (17.9%) | Trimethoprim: 72,705 (11.2%) Nitrofurantoin: 38,625 (16.7%) |
Number of antimicrobials received per patient | ||
 1  2  3  4  5 | 491,315 (44.9%) 402,731 (36.8%) 144,671 (13.2%) 44,179 (4.0%) 10,331 (0.9%) | 590,438 (54.0%) 161,787 (14.8%) |